M-SET
Cross-source consensus on M-SET from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Risks & contraindications
Other
Highlighted claims
- The M-SET was developed to systematically assess side effects across the full course of MDMA-assisted psychotherapy. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The M-SET was designed to collect safety information during screening, baseline, acute treatment, and follow-up. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The final M-SET contains 165 items across four questionnaires. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The M-SET is intended for clinical trials and real-world clinical implementation. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The acute treatment questionnaire includes vital signs monitoring, dosing details, clinician-rated tolerability, and discharge assessment. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
- The M-SET is comprehensive and may impose participant burden, especially during repeated acute-treatment symptom assessments. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study